Revance Therapeutics, Inc.

Zurcher Kantonalbank (Zurich Cantonalbank)

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/7/2025

Shares

32,961

Value ($000)

100

Weight

0.0%

2014 Q1 - 2024 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/7/2025	100	0.0%	32,961	12/31/2024
2024 Q3	11/14/2024	171	0.0%	32,961	9/30/2024
2024 Q2	7/29/2024	85	0.0%	32,961	6/30/2024
2024 Q1	4/25/2024	110	0.0%	22,323	3/31/2024
2023 Q4	1/30/2024	159	0.0%	18,083	12/31/2023
2023 Q3	10/25/2023	207	0.0%	18,083	9/30/2023
2023 Q2	8/7/2023	391	0.0%	15,461	6/30/2023
2023 Q1	5/8/2023	461	0.0%	14,327	3/31/2023
2022 Q4	2/1/2023	256	0.0%	13,871	12/31/2022
2022 Q3	11/9/2022	213	0.0%	7,882	9/30/2022
2022 Q2	8/9/2022	109	0.0%	7,882	6/30/2022
2022 Q1	4/21/2022	154	0.0%	7,882	3/31/2022
2021 Q4	2/1/2022	129	0.0%	7,882	12/31/2021
2021 Q3	11/15/2021	220	0.0%	7,882	9/30/2021
2021 Q2	7/30/2021	234	0.0%	7,882	6/30/2021
2021 Q1	5/3/2021	220	0.0%	7,882	3/31/2021
2020 Q4	1/28/2021	223	0.0%	7,882	12/31/2020
2020 Q3	11/6/2020	198	0.0%	7,882	9/30/2020
2020 Q2	7/28/2020	192	0.0%	7,882	6/30/2020
2020 Q1	5/6/2020	56	0.0%	3,807	3/31/2020
2019 Q4	1/21/2020	44	0.0%	2,727	12/31/2019
2014 Q2	8/6/2014	4,420	0.1%	130,000	6/30/2014
2014 Q1	4/29/2014	3,150	0.1%	100,000	3/31/2014